Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-30 Hansen Gwenn Chief Scientific Officer Sale −1,412 $11.78 $17K 23,009
2023-01-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 38,481
2022-10-31 van Houte Hans Chief Financial Officer Sale −739 $12.88 $10K 74,803
2022-10-31 Ring Christine General Counsel Sale −699 $12.88 $9K 6,185
2022-10-31 Hansen Gwenn Chief Scientific Officer Sale −1,165 $12.88 $15K 21,214
2022-10-31 Wolff Stefani EVP and COO Sale −350 $12.88 $5K 3,402
2022-10-30 van Houte Hans Chief Financial Officer Option exercise +2,886 75,542
2022-10-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,886 37,519
2022-10-30 Ring Christine General Counsel Option exercise +1,924 6,884
2022-10-30 Ring Christine General Counsel Option exercise · Restricted Stock Units −1,924 25,013
2022-10-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,207 22,379
2022-10-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,207 41,688
2022-10-30 Wolff Stefani EVP and COO Option exercise +962 3,752
2022-10-30 Wolff Stefani EVP and COO Option exercise · Restricted Stock Units −962 12,506
2022-09-12 Saltzman Edward C Director Grant or award · Director Stock Option (right to buy) +50,000 50,000
2022-08-09 Ring Christine General Counsel Grant or award · Employee Stock Option (right to buy) +40,199 40,199
2022-08-09 Wolff Stefani EVP and COO Grant or award · Employee Stock Option (right to buy) +110,375 110,375
2022-08-09 van Houte Hans Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +120,000 120,000
2022-08-09 SANDS ARTHUR T President, CEO Grant or award · Employee Stock Option (right to buy) +400,000 400,000
2022-08-09 Hansen Gwenn Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +60,298 60,298

Page 27 of 32 · 632 trades